These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 6392343

  • 1. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M, Williams PS, Solomon SD, Rubin AL, Stenzel KH.
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [Abstract] [Full Text] [Related]

  • 2. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ, van Krimpen BA, Ronteltap CP, Bolhuis RL.
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [Abstract] [Full Text] [Related]

  • 3. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 4. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 01; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 5. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 6. Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones.
    Moretta A, Pantaleo G, Lopez-Botet M, Mingari MC, Carrel S, Moretta L.
    Eur J Immunol; 1985 Aug 01; 15(8):841-4. PubMed ID: 3161746
    [Abstract] [Full Text] [Related]

  • 7. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A, Pantaleo G, Mingari MC, Melioli G, Moretta L, Cerottini JC.
    Eur J Immunol; 1984 Feb 01; 14(2):121-5. PubMed ID: 6230242
    [Abstract] [Full Text] [Related]

  • 8. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
    Moretta A, Pantaleo G, Lopez-Botet M, Carrel S, Moretta L.
    Behring Inst Mitt; 1985 Aug 01; (77):39-47. PubMed ID: 2417584
    [Abstract] [Full Text] [Related]

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 10. Involvement of T3 and T8 molecules in human T cell receptor function. Anti-T3 or anti-T8 antibodies do not block the antigen-dependent activation of a subset of alloreactive cytolytic T cell precursors.
    Moretta A, Pantaleo G, Mingari MC, Moretta L.
    Eur J Immunol; 1985 Aug 01; 15(8):803-8. PubMed ID: 3161744
    [Abstract] [Full Text] [Related]

  • 11. A reappraisal of the effects of monoclonal antibodies directed at T cell differentiation antigens.
    Suthanthiran M, Evelyn M, Rubin AL, Stenzel KH.
    Transplantation; 1984 Dec 01; 38(6):720-6. PubMed ID: 6239416
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb 01; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T, Seemayer TA, Lapp WS.
    Transplantation; 1987 Aug 01; 44(2):254-60. PubMed ID: 3498241
    [Abstract] [Full Text] [Related]

  • 14. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
    Scott CF, Bolender S, McIntyre GD, Holldack J, Lambert JM, Venkatesh YP, Morimoto C, Ritz J, Schlossman SF.
    J Immunol; 1989 Jun 01; 142(11):4105-12. PubMed ID: 2565930
    [Abstract] [Full Text] [Related]

  • 15. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE, Caulfield JP, Michon J, Hein A, Kamada MM, MacDermott RP, Stevens RL, Ritz J.
    J Immunol; 1988 Feb 01; 140(3):991-1002. PubMed ID: 3276787
    [Abstract] [Full Text] [Related]

  • 16. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
    Lopez-Botet M, Moretta L.
    J Immunol; 1985 Apr 01; 134(4):2299-304. PubMed ID: 3919089
    [Abstract] [Full Text] [Related]

  • 17. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW, Mikovits JA, Kalyanaraman VS, Overton R, Stevenson H, Stromberg K, Herberman RB, Farrar WL, Ortaldo JR.
    J Immunol; 1986 May 15; 136(10):3619-24. PubMed ID: 2422259
    [Abstract] [Full Text] [Related]

  • 18. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ, Bolhuis RL, Stoter G, Roozemond RC.
    J Immunol; 1987 May 15; 138(10):3137-44. PubMed ID: 2952709
    [Abstract] [Full Text] [Related]

  • 19. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ, Giphart MJ, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1984 Sep 15; 133(3):1222-9. PubMed ID: 6205072
    [Abstract] [Full Text] [Related]

  • 20. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
    Platsoucas CD.
    Eur J Immunol; 1984 Jun 15; 14(6):566-77. PubMed ID: 6610558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.